<DOC>
	<DOCNO>NCT02431897</DOCNO>
	<brief_summary>This study randomize postmenopausal woman symptomatic pelvic organ prolapse plan native tissue transvaginal surgical repair 6-8 week preoperative 1-year continued postoperative vaginal estrogen cream compare placebo cream . This clinical trial basic science investigation design understand mechanism local estrogen treatment affect connective tissue pelvic floor determine whether use prolapse repair ( ) improve success rate surgical intervention minimize prolapse recurrence ( ii ) impact favorably upon symptom pelvic floor disorder .</brief_summary>
	<brief_title>Investigation Minimize Prolapse Recurrence Vagina Using Estrogen</brief_title>
	<detailed_description>This double-blind randomized trial intravaginal estrogen ( conjugate estrogen , 0.625mg/1g cream ) vs. placebo postmenopausal woman ( n=222 total ) symptomatic prolapse beyond hymen plan transvaginal native tissue repair . Medication start 6-8 week surgery continue 1 year postoperatively , i.e . scar remodel complete . The investigator aim determine pre- postoperative intravaginal estrogen therapy ( ) result anatomic patient-reported subjective improvement pelvic organ support , ( ii ) impact pelvic floor disorder ( overactive bladder incontinence , sexual function pain , postoperative cystitis ) , satisfaction , quality life , vaginal wound healing . Finally , ( iii ) investigator determine potential mechanism local estrogen treatment alters pelvic organ support examine full-thickness vaginal wall biopsy take time surgery histologic , connective tissue , smooth muscle synthesis degradative change . The investigator expect highlight novel target future therapy prolapse repair prevention .</detailed_description>
	<mesh_term>Recurrence</mesh_term>
	<mesh_term>Prolapse</mesh_term>
	<mesh_term>Pelvic Organ Prolapse</mesh_term>
	<mesh_term>Cystocele</mesh_term>
	<mesh_term>Uterine Prolapse</mesh_term>
	<mesh_term>Pelvic Floor Disorders</mesh_term>
	<mesh_term>Estrogens , Conjugated ( USP )</mesh_term>
	<mesh_term>Estrogens</mesh_term>
	<criteria>Postmenopausal : menses &gt; 1 year Minimum age : 48 year Symptomatic apical and/or anterior vaginal wall prolapse , stage 2 great No estrogen replacement within last month ( may come current treatment , i.e . wash , join study ) Medically fit elective surgery Physically able apply/insert study drug Available clinic followup minimum 1yr Concurrent use steroid cream indication ( e.g . lichen sclerosis ) BMI &gt; 35 kg/m2 Recent history ( within last month ) vaginal infection vaginitis Contraindications estrogen therapy ( e.g . spontaneous DVT , stroke , breast endometrial/ hormoneresponsive cancer , genital bleed unknown cause ) History connective tissue disease Any oral transdermal estrogen , SERM , medication impact vaginal milieu History vaginal irradiation Allergy Premarin constituent Prior apical repair use mesh prolapse repair Current tobacco use</criteria>
	<gender>Female</gender>
	<minimum_age>48 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2016</verification_date>
	<keyword>Pelvic Organ Prolapse</keyword>
	<keyword>Pelvic Floor Disorders</keyword>
	<keyword>Therapy , Estrogen Replacement</keyword>
	<keyword>Estrogens , Conjugated</keyword>
</DOC>